Pulmonary neuroendocrine neoplasms are classified by WHO as either typical or atypical
carcinoids, large cell (LCNEC) or small cell (SCLC) neuroendocrine carcinoma based on …

Pulmonary carcinoid tumors, including typical and atypical carcinoids, are well‑differentiated
neuroendocrine tumors (NETs) that represent 1‑2% of all lung cancer cases. In the present …

Pulmonary neuroendocrine neoplasms comprise~ 20% of all lung tumors. Typical carcinoid,
atypical carcinoid, small cell carcinoma, and large cell neuroendocrine carcinoma represent …

Background Pulmonary neuroendocrine neoplasms can be divided into typical carcinoid,
atypical carcinoid, large cell neuroendocrine carcinoma, and small cell (lung) carcinoma …

In the lung, neuroendocrine tumors (NETs), namely typical and atypical carcinoids, and
neuroendocrine carcinomas (NECs), grouping small cell carcinoma (SCLC) and large cell …

Background The histopathologic distinction between typical carcinoid (TC) and atypical
carcinoid (AC) of the lung is based largely on mitotic index. Ki-67 may aid in separation of …

The worldwide incidence of pulmonary carcinoids is increasing, but little is known about
their molecular characteristics. Through machine learning and multi-omics factor analysis …

In the recently published 2015 World Health Organization (WHO) classification of tumors of
the lungs, all neuroendocrine tumors of the lungs are presented for the first time in one …

Bronchopulmonary neuroendocrine tumors are an uncommon group of neoplasms,
accounting for about 20% of all lung carcinomas, arising from stem cells of the bronchial …

Little is known as to whether there may be any pathogenetic link between pulmonary
carcinoids and neuroendocrine carcinomas (NECs). A gene signature we previously found …